“Vivli is delighted to have Otsuka join as our newest member,” said Rebecca Li, Vivli Executive Director. “They are making an important contribution in sharing their trial data with researchers to advance science.”
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka Pharmaceutical Co., Ltd. and its subsidiaries, such as Otsuka Pharmaceutical Development & Commercialization, Inc., research, develop, manufacture, and market innovative products, with a focus on pharmaceutical products to meet unmet medical needs and nutraceutical products for the maintenance of everyday health.
In pharmaceuticals, Otsuka is a leader in the challenging areas of mental, renal and cardiovascular health and has additional research programs in oncology and on several under-addressed diseases including tuberculosis, a significant global public health issue. These commitments illustrate how Otsuka is a “big venture” company at heart, applying a youthful spirit of creativity in everything it does.
“We are excited to join Vivli’s global data sharing platform to help advance clinical development and innovation,” said Christoph Koenen, MD, executive vice president and chief medical officer, from Otsuka Pharmaceutical Development & Commercialization, Inc. “Patients are at the center of everything we do at Otsuka and data sharing is increasing in importance as we develop novel treatments for people living with complex diseases.”